Abstract
Syndrome differentiation is a methodology unique to Chinese medicine. It threads the diagnosis process with clinical treatment into a holistic web of links to determine and regulate the patterns of dysfunctions in the human body. It is seen as the essence of Chinese medicine because it takes into account the theoretical principles, diagnostic methodologies and the modality of treatment holistically. In this process the progressive development and changes of syndromes are also considered by the physician. This paper is a systematic study of the methodology of syndrome differentiation in relation to its clinical applications in the treatment of diseases. To illustrate the efficacy of syndrome differentiation, the relationship between pattern identification and diseases is analysed to provide a guiding principle for integration between Chinese medicine and Western medicine. Diseases being selected include cancer, cardiovascular and metabolic syndromes. A study of renal and hepatic diseases related to lifestyle is also included to highlight the clinical efficacy of syndrome differentiation. The paper also includes an analytical summary of the theoretical advancements made in integrative differentiation methodology during the past five decades which links to the recent clinical thinking and practice.
Similar content being viewed by others
References
The Five Methods of Differentiation were proposed during the 1983 National Conference on Medical Differentiation of Syndromes.
Su W, Xu ZY, Wang ZQ, Xu JT. Objectified study on tongue images of patients with lung cancer of different syndromes. Chin J Integr Med 2011;17:272–276.
Mei MF. Diagnostic thoughts in medicine—a Chinese-Western comparative study. Delivered at the 6th World Congress of Chinese Medicine 5–6th December 2009, Melbourne, Australia
Shang Han Lun 伤寒论 (Treatise of the Cold Injury) compiled by Zhang Zhong-jing in Han Dynasty 220 AD.
Sun XG, Zhong XL, Liu ZF, Cai HB, Fan Q, Wang QR, et al. Proteomic analysis of chronic restraint stress-induced Liver (Gan)-stagnancy syndrome in rats. Chin J Integr Med 2010;16:510–517.
Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, et al. Indirubin, the active constitute of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999;1:60–67.
Feng Y, Xu H, Qu D, Zheng F, Shi DZ, Chen KJ. Study on the tongue manifestation for the blood-stasis and toxin syndrome in the stable patients of coronary heart disease. Chin J Integr Med 2011;17:333–338.
Xu H, Chen KJ. Integrative medicine: the experience from China. J Altern Complem Med 2008;14:3–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
Chinese Medical Institute and Register (CMIR), Chinese Medical Council (CMC), China-UK Consortium for Medical Integration, Research and Collaboration (CUC), World Federation of Chinese Medicine Societies (WFCMS)
Rights and permissions
About this article
Cite this article
Mei, M.F. A systematic analysis of the theory and practice of syndrome differentiation. Chin. J. Integr. Med. 17, 803–810 (2011). https://doi.org/10.1007/s11655-011-0890-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-011-0890-0